Back to Search
Start Over
Vascular endothelial growth factor: A potential target of therapy in neuromyelitis optica?
- Source :
- Clinical and Experimental Neuroimmunology. 6:349-350
- Publication Year :
- 2015
- Publisher :
- Wiley, 2015.
-
Abstract
- An open study was conducted to evaluate the safety of bevacizumab, anti-vascular endothelial growth factor antibody, in patients with neuromyelitis optica developing signs of relapse.
- Subjects :
- Oncology
medicine.medical_specialty
Neuromyelitis optica
Bevacizumab
biology
business.industry
Growth factor
medicine.medical_treatment
Immunology
Neuroscience (miscellaneous)
medicine.disease
eye diseases
Open study
Vascular endothelial growth factor A
Immunology and Microbiology (miscellaneous)
Internal medicine
medicine
biology.protein
In patient
Neurology (clinical)
Antibody
business
medicine.drug
Subjects
Details
- ISSN :
- 17591961
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- Clinical and Experimental Neuroimmunology
- Accession number :
- edsair.doi...........e045b9c047d81d0e3adc9a0a93002e3b
- Full Text :
- https://doi.org/10.1111/cen3.12258